Intellect Neurosciences

About:

Intellect Neurosciences is engaged in the R&D of disease-modifying drugs for the prevention of neurological disorders such as Alzheimer's.

Website: http://intellectns.com

Description:

Intellect Neurosciences Inc. is a New York based biopharmaceutical company engaged in the discovery and development of a new breed of innovative “disease-modifying” therapeutic drugs designed to slow, arrest and ultimately prevent Alzheimer's disease and other serious neurological disorders.

Total Funding Amount:

$2.77M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

New York, New York, United States

Founded Date:

2005-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2010-05-13

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai